Fluorocort (Ftorocort)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceTriamcinoloneTriamcinolone
Similar drugsTo uncover
  • Kenalog®
    pills inwards 
    KRKA, dd, Novo mesto, AO    
  • Kenalog®
    suspension for injections 
    Bristol-Myers Squibb Company     Italy
  • Kenalog® 40
    suspension for injections 
    KRKA, dd, Novo mesto, AO    
  • Polcortolone
    pills inwards 
    Pabianicki Pharmaceutical Plant Polfa, JSC     Poland
  • Triacort®
    ointment externally 
    AKRIKHIN HFK, JSC     Russia
  • Triamcinolone-FPO®
    pills inwards 
    OBOLENSKOE PHARMACEUTICAL ENTERPRISE, CJSC     Russia
  • Fluorocort
    ointment externally 
    GEDEON RICHTER, OJSC     Hungary
    • Dosage form: & nbspOintment for external use.
    Composition:
    (per 1 g of ointment):

    Active substance: triamcinolone acetonide 0.001 g

    Excipients: methylparahydroxybenzoate, stearic acid, polysorbate 60, cetyl alcohol, paraffin liquid, glycerol 85%, purified water.
    Description:White or almost white homogeneous ointment, practically odorless.

    Pharmacotherapeutic group:Glucocorticosteroid for topical application.
    ATX: & nbsp

    H.02.A.B.08   Triamcinolone

    Pharmacodynamics:Glucocorticosteroid (CGS) for external use; has a local anti-inflammatory, anti-allergic, anti-edematous and antiproliferative effect. When exposed to the skin, the edge accumulation of neutrophils is prevented, which leads to a decrease in exudation, production of cytokines, inhibition of migration of macrophages, leading ultimately to a decrease in the processes of infiltration and granulation.
    Pharmacokinetics:
    Triamcinolone is rapidly distributed in the tissues of the body. The main metabolite of triamcinolone is 6-β-hydroxytriamcinolone. It is excreted through the intestines and kidneys, in equal proportions. The half-life of triamcinolone from the plasma is about 5 hours, the half-life of tissues is 18-36 hours.
    Indications:Skin diseases sensitive to glucocorticosteroids: acute and chronic eczema, neurodermatitis, contact dermatitis, lichen planus, psoriasis, exfoliative erythroderma, Leyner's disease, external otitis, not complicated by infection, insect bites.
    Contraindications:Hypersensitivity to any of the components of the drug, tuberculosis, viral, bacterial and fungal skin infections, trophic ulcers of the lower leg, rosacea, vulgar acne, perioral dermatitis, diaper rash, children under 2 years old. Do not apply to wounds.
    Carefully:
    Pregnancy, lactation.

    Pregnancy and lactation:
    The use of Fluorocorta in pregnant women is allowed in cases where the potential benefit to the mother prevails over the possible risk to the fetus. It is not known whether the drug penetrates into breast milk, so during lactation it is necessary to refuse breastfeeding.
    Dosing and Administration:
    Outwardly.
    The drug is applied a thin layer on the affected skin 2-3 times a day (maximum daily dose of 15 g). The use of an occlusive dressing is possible, the maximum amount of ointment should not exceed 10 g. The course of treatment is usually 5-10 days, with a persistent course - up to 25 days, the use of more than 4 weeks is not recommended.
    Side effects:Side effects with external application develop rarely and are reversible. Itching, skin irritation, contact eczema, steroid acne, purpura. With prolonged use - the development of secondary infectious lesions and trophic skin changes.
    Overdose:Data on the overdose of the drug Ftorokort are absent.
    Interaction:With external use of glucocorticosteroids, interaction with other drugs is unknown.
    Special instructions:
    If side effects occur, stop using Ftorocort.
    Like other local glucocorticosteroids, the preparation Fluorocort can not be applied to the skin in the eye area, as well as on the wound surfaces. When using occlusive dressings and using on large surfaces of the body, the systemic effect of the drug is possible - in such cases more caution is required, especially when treating children.
    If the course of the disease is complicated by the development of a secondary bacterial or fungal infection, a specific antibacterial or antifungal agent should be added to the therapy with Fluorocort. With extreme caution, use the drug on the face.
    Use in children should be done with caution. It should be borne in mind that in young children, skin folds and diapers can have an effect similar to the effect of an occlusive dressing, and increase the systemic resorption of the drug. In addition, children can have a greater degree of systemic resorption due to the relationship between skin surface and body weight, and also due to insufficient maturation of the skin.
    The duration of treatment in children should not exceed 5 days. Longer use of the drug should be under the supervision of a doctor. The use of an occlusive dressing for children is not recommended.
    Effect on the ability to drive transp. cf. and fur:The drug does not affect the abilities necessary for driving or working with machinery.
    Form release / dosage:Ointment for external use 0,1%.
    Packaging:For 15 g of the drug in an aluminum tube with a sealed membrane with a screwed polyethylene cap. One tube in a cardboard box with the attached instructions for use.
    Storage conditions:Store at a temperature of 8 to 15 ° C. Keep out of the reach of children!
    Shelf life:2 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:П N011862 / 01
    Date of registration:02.06.2010
    The owner of the registration certificate:GEDEON RICHTER, OJSC GEDEON RICHTER, OJSC Hungary
    Manufacturer: & nbsp
    Representation: & nbspGEDEON RICHTER OJSC GEDEON RICHTER OJSC Hungary
    Information update date: & nbsp23.09.2015
    Illustrated instructions
      Instructions
      Up